Liao CT, Huang JL, Liang HW, et al. - On comparing acute decompensated heart failure (HF) with reduced ejection fraction (HFrEF) patients who were given ivabradine at discharge vs those who were not, findings revealed decreased risks of cardiovascular mortality, all-cause mortality, and HF rehospitalization within 1 year in relation to ivabradine treatment in real-world settings.

• A total of 876 patients were analyzed; including 292 and 584 patients with and without ivabradine treatment at discharge, respectively.

• For adjusting confounders, propensity score matching was applied.

• Baseline characteristics did not differ significantly between the two groups.